Core Viewpoint - The announcement highlights the successful market entry and commercialization of the Iberis® RDN system by the company's subsidiary, Shanghai Antong Medical Technology Co., Ltd, in Switzerland, marking a significant milestone in the company's product development and market strategy [1] Group 1: Product Development - The Iberis® RDN system has completed market access and the first commercial procedure in Switzerland, performed at the University Hospital of Basel, with no reported complications or adverse events [1] - The Iberis® RDN system is the only renal denervation (RDN) product globally approved for both transradial access (TRA) and transfemoral access (TFA) methods, enhancing safety, efficacy, and cost-effectiveness [1] Group 2: Strategic Partnerships - The company has established a strategic partnership with Bosheng International Group for the commercialization of the Iberis® RDN system, covering multiple regions including the EU, Asia-Pacific, and Latin America [1] Group 3: Regulatory Approvals - The Iberis® RDN system received CE marking in Europe in 2016, indicating its compliance with health, safety, and environmental protection standards for products sold within the European Economic Area [1]

本 公 告 乃 由 上 海 百 心 安 生 物 技 術 股 份 有 限 公 司（「本公司」，連 同 其 附 屬 公 司 統 稱「本集團」）自 願 作 出，以 向 本 公 司 股 東 及 潛 在 投 資 者 提 供 有 關 本 集 團 最 新 業 務 發 展 情 況 的 最 新 資 料。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不會就本公告全部或任何部分內容而產生或因依賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 Shanghai Bio-heart Biological Technology Co., Ltd. 上海百心安生物技術股份有限公司 （於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司） （股 份 代 號：2185） 自願公告 IBERIS® RDN系統於瑞士的首個商業案例 承董事會命 本 公 司 董 事 會（「董事會」）欣 然 宣 佈，最 近，本 公 司 附 屬 公 司 上 海 安 通 醫 療 科 技 有 限 公 司（「安 通 ...

Core Viewpoint - Baixinan-B (02185) shares rose over 6%, reaching HKD 8.71 with a trading volume of HKD 5.1305 million, following a notification from its controlling shareholder Wang Li regarding plans to increase his stake in the company [1] Group 1: Shareholder Actions - Wang Li plans to acquire additional H shares of Baixinan through Winning Powerful Limited, a wholly-owned company, within approximately 12 months from the announcement date [1] - The total amount Wang Li intends to invest in the share acquisition is expected to be no more than HKD 15 million [1] - As of the announcement date, Winning Powerful Limited holds 45.6456 million H shares, representing about 18.75% of the company's issued shares [1]

Core Viewpoint - Baixinan-B (02185) shares rose over 6%, reaching HKD 8.71 with a trading volume of HKD 5.1305 million, following the announcement of a share buyback plan by its controlling shareholder, Wang Li [1] Group 1: Shareholder Actions - Wang Li, the controlling shareholder, plans to increase his stake in Baixinan-B through Winning Powerful Limited, a wholly-owned company, with a total investment not exceeding HKD 15 million within approximately 12 months [1] - Winning Powerful Limited currently holds 45.6456 million H shares, representing about 18.75% of the company's issued shares [1] Group 2: Market Reaction - Following the announcement, Baixinan-B's stock price increased by 6.22% [1] - The market is responding positively to the confidence expressed by the controlling shareholder regarding the company's future growth potential [1]

Core Insights - On October 20, 2023, shareholders of Baixinan-B (02185) transferred shares from China Securities Depository and Clearing Hong Kong to Morgan Stanley Hong Kong Securities, with a transfer market value of HKD 135 million, accounting for 6.68% of the total shares [1] Group 1 - Baixinan-B announced that its controlling shareholder, Wang Li, plans to increase his stake in the company over the next 12 months through Winning Powerful Limited, a wholly-owned company registered in Hong Kong, with an expected total investment not exceeding HKD 15 million [1] - As of the announcement date, Winning Powerful Limited directly holds 45.6456 million H shares of the company, representing approximately 18.75% of the total issued shares [1]

Core Viewpoint - The recent stock transfer and planned share acquisition by the controlling shareholder indicate confidence in the company's future growth potential and overall business development [1] Group 1: Stock Transfer - On October 20, the shareholder of Baixinan-B (02185) transferred shares from China Securities Depository and Clearing Hong Kong to Morgan Stanley Hong Kong Securities, with a market value of HKD 135 million, accounting for 6.68% of the total shares [1] Group 2: Share Acquisition Plan - On the same date, Baixinan-B announced that its controlling shareholder, Wang Li, plans to acquire additional H shares in the open market through Winning Powerful Limited, a wholly-owned company, with a total amount not exceeding HKD 15 million within approximately 12 months [1] - As of the announcement date, Winning Powerful Limited directly holds 45.6456 million H shares, representing about 18.75% of the company's issued shares [1]

Core Viewpoint - RAYS Capital Partners Limited has increased its stake in Baixinan-B (02185) by acquiring 800,000 shares at a price of HKD 8.749 per share, totaling HKD 6.9992 million, raising its ownership to 11.8682 million shares, which represents 5.03% of the company [1] Summary by Category - **Share Acquisition** - RAYS Capital Partners Limited purchased 800,000 shares of Baixinan-B at HKD 8.749 each [1] - The total investment amounted to HKD 6.9992 million [1] - **Ownership Update** - Following the acquisition, RAYS Capital's total shareholding in Baixinan-B is now 11.8682 million shares [1] - The new ownership percentage stands at 5.03% [1]

Group 1 - RAYS Capital Partners Limited increased its stake in Baixinan-B (02185.HK) by purchasing 800,000 shares at an average price of HKD 8.749 per share, totaling approximately HKD 6.9992 million [1] - Following the acquisition, RAYS Capital Partners Limited's total shareholding rose to 11.8682 million shares, increasing its ownership percentage from 4.69% to 5.03% [1]

Core Viewpoint - The company received a notification from its controlling shareholder, Wang Li, indicating plans to increase his stake in the company through a subsidiary within the next 12 months, reflecting confidence in the company's value and growth potential [1] Group 1: Shareholder Actions - Wang Li plans to acquire additional H-shares of the company through Winning Powerful Limited, with a total investment not exceeding HKD 15 million [1] - Winning Powerful Limited currently holds approximately 45.6456 million H-shares, representing about 18.75% of the company's issued shares [1]

Core Viewpoint - The company, 百心安-B (02185.HK), announced that its controlling shareholder, 汪立, plans to increase his stake in the company through a subsidiary, Winning Powerful Limited, with a total investment not exceeding HKD 15 million over the next 12 months [1] Group 1 - The controlling shareholder, 汪立, recognizes the company's value and has confidence in its future business development and growth potential [1] - Winning Powerful Limited, fully owned by 汪立, currently holds 45,645,584 H shares, representing approximately 18.75% of the company's issued shares [1] - The share acquisition will occur in the open market using the subsidiary's own funds, subject to market conditions and regulatory requirements [1]